Oramed shareholders re-elect all seven directors, approve say-on-pay, ratify auditor at 2024 annual meeting

ORAMED PHARMACEUTICALS INC.

All seven director nominees re-elected with majority votes; top vote-getter Benjamin Shapiro had 10,120,322 for.
Advisory vote on executive compensation passed: 9,171,779 for, 1,016,334 against.
Ratification of Kesselman & Kesselman (PwC Israel) as FY 2024 auditor approved: 17,323,361 for.
Broker non-votes of 7,236,740 on director elections and say-on-pay due to lack of discretionary voting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.